Understanding When to use DPP-4 inhibitors?
•
5 min read
An estimated 425 million people worldwide had diabetes in 2017, with the prevalence expected to climb to 629 million by 2045. To manage this condition, Dipeptidyl Peptidase-4 (DPP-4) inhibitors, or gliptins, are a class of oral medications used with diet and exercise to help control high blood sugar in adults with type 2 diabetes.
